EMEA (Europe, Middle East and Africa) Gene Therapy Market Report 2018

March 2018 | 105 pages | ID: E22B8838B8AQEN
QYResearch

Abstracts

In this report, the EMEA Gene Therapy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Gene Therapy for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gene Therapy market competition by top manufacturers/players, with Gene Therapy sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical
• Advantagene

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Ex vivo
• In vivo

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer Diseases
• Monogenic Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Gene Therapy Market Report 2018

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy
  1.2.1 EMEA Gene Therapy Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Ex vivo
  1.2.4 In vivo
1.3 EMEA Gene Therapy Market by Application/End Users
  1.3.1 EMEA Gene Therapy Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer Diseases
  1.3.3 Monogenic Diseases
  1.3.4 Infectious Diseases
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 EMEA Gene Therapy Market by Region
  1.4.1 EMEA Gene Therapy Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Gene Therapy (2013-2025)
  1.5.1 EMEA Gene Therapy Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Gene Therapy Revenue and Growth Rate (2013-2025)

2 EMEA GENE THERAPY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Gene Therapy Market Competition by Players/Manufacturers
  2.1.1 EMEA Gene Therapy Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Gene Therapy Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Gene Therapy Sale Price by Players (2013-2018)
2.2 EMEA Gene Therapy (Volume and Value) by Type/Product Category
  2.2.1 EMEA Gene Therapy Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Gene Therapy Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Gene Therapy Sale Price by Type (2013-2018)
2.3 EMEA Gene Therapy (Volume) by Application
2.4 EMEA Gene Therapy (Volume and Value) by Region
  2.4.1 EMEA Gene Therapy Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Gene Therapy Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Gene Therapy Sales Price by Region (2013-2018)

3 EUROPE GENE THERAPY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Gene Therapy Sales and Value (2013-2018)
  3.1.1 Europe Gene Therapy Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Gene Therapy Revenue and Growth Rate (2013-2018)
3.2 Europe Gene Therapy Sales and Market Share by Type
3.3 Europe Gene Therapy Sales and Market Share by Application
3.4 Europe Gene Therapy Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Gene Therapy Sales Volume by Countries (2013-2018)
  3.4.2 Europe Gene Therapy Revenue by Countries (2013-2018)
  3.4.3 Germany Gene Therapy Sales and Growth Rate (2013-2018)
  3.4.4 France Gene Therapy Sales and Growth Rate (2013-2018)
  3.4.5 UK Gene Therapy Sales and Growth Rate (2013-2018)
  3.4.6 Russia Gene Therapy Sales and Growth Rate (2013-2018)
  3.4.7 Italy Gene Therapy Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Gene Therapy Sales and Growth Rate (2013-2018)

4 MIDDLE EAST GENE THERAPY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Gene Therapy Sales and Value (2013-2018)
  4.1.1 Middle East Gene Therapy Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Gene Therapy Revenue and Growth Rate (2013-2018)
4.2 Middle East Gene Therapy Sales and Market Share by Type
4.3 Middle East Gene Therapy Sales and Market Share by Application
4.4 Middle East Gene Therapy Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Gene Therapy Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Gene Therapy Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Gene Therapy Sales and Growth Rate (2013-2018)
  4.4.4 Israel Gene Therapy Sales and Growth Rate (2013-2018)
  4.4.5 UAE Gene Therapy Sales and Growth Rate (2013-2018)
  4.4.6 Iran Gene Therapy Sales and Growth Rate (2013-2018)

5 AFRICA GENE THERAPY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Gene Therapy Sales and Value (2013-2018)
  5.1.1 Africa Gene Therapy Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Gene Therapy Revenue and Growth Rate (2013-2018)
5.2 Africa Gene Therapy Sales and Market Share by Type
5.3 Africa Gene Therapy Sales and Market Share by Application
5.4 Africa Gene Therapy Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Gene Therapy Sales Volume by Countries (2013-2018)
  5.4.2 Africa Gene Therapy Revenue by Countries (2013-2018)
  5.4.3 South Africa Gene Therapy Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Gene Therapy Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Gene Therapy Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Gene Therapy Sales and Growth Rate (2013-2018)

6 EMEA GENE THERAPY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sangamo
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gene Therapy Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Spark Therapeutics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gene Therapy Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Dimension Therapeutics
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gene Therapy Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Avalanche Bio
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gene Therapy Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Celladon
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gene Therapy Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Vical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Gene Therapy Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vical Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Advantagene
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Gene Therapy Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GENE THERAPY MARKET FORECAST (2018-2025)

11.1 EMEA Gene Therapy Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Gene Therapy Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Gene Therapy Price and Trend Forecast (2018-2025)
11.2 EMEA Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Gene Therapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Gene Therapy Sales Forecast by Type (2018-2025)
11.7 EMEA Gene Therapy Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gene Therapy
Figure EMEA Gene Therapy Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Gene Therapy Sales Volume Market Share by Type (Product Category) in 2017
Figure Ex vivo Product Picture
Figure In vivo Product Picture
Figure EMEA Gene Therapy Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Gene Therapy by Application in 2017
Figure Cancer Diseases Examples
Table Key Downstream Customer in Cancer Diseases
Figure Monogenic Diseases Examples
Table Key Downstream Customer in Monogenic Diseases
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Gene Therapy Market Size (Million USD) by Region (2013-2025)
Figure Europe Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Gene Therapy Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gene Therapy Sales Volume and Growth Rate (2013-2025)
Figure EMEA Gene Therapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Gene Therapy Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Gene Therapy Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Gene Therapy Sales Share by Players (2013-2018)
Figure 2017 Gene Therapy Sales Share by Players
Figure 2017 Gene Therapy Sales Share by Players
Figure EMEA Gene Therapy Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Gene Therapy Revenue (Million USD) by Players (2013-2018)
Table EMEA Gene Therapy Revenue Share by Players (2013-2018)
Table 2017 EMEA Gene Therapy Revenue Share by Players
Table 2017 EMEA Gene Therapy Revenue Share by Players
Table EMEA Gene Therapy Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Gene Therapy Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Gene Therapy Sales Share by Type (2013-2018)
Figure Sales Market Share of Gene Therapy by Type (2013-2018)
Figure EMEA Gene Therapy Sales Market Share by Type (2013-2018)
Table EMEA Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Gene Therapy Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type in 2017
Table EMEA Gene Therapy Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Gene Therapy Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Gene Therapy Sales Share by Application (2013-2018)
Figure Sales Market Share of Gene Therapy by Application (2013-2018)
Figure EMEA Gene Therapy Sales Market Share by Application in 2017
Table EMEA Gene Therapy Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Gene Therapy Sales Share by Region (2013-2018)
Figure Sales Market Share of Gene Therapy by Region (2013-2018)
Figure EMEA Gene Therapy Sales Market Share in 2017
Table EMEA Gene Therapy Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Gene Therapy Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Gene Therapy by Region (2013-2018)
Figure EMEA Gene Therapy Revenue Market Share Regions in 2017
Table EMEA Gene Therapy Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Gene Therapy Revenue and Growth Rate (2013-2018)
Table Europe Gene Therapy Sales (K Units) by Type (2013-2018)
Table Europe Gene Therapy Market Share by Type (2013-2018)
Figure Europe Gene Therapy Market Share by Type in 2017
Table Europe Gene Therapy Sales (K Units) by Application (2013-2018)
Table Europe Gene Therapy Market Share by Application (2013-2018)
Figure Europe Gene Therapy Market Share by Application in 2017
Table Europe Gene Therapy Sales (K Units) by Countries (2013-2018)
Table Europe Gene Therapy Sales Market Share by Countries (2013-2018)
Figure Europe Gene Therapy Sales Market Share by Countries (2013-2018)
Figure Europe Gene Therapy Sales Market Share by Countries in 2017
Table Europe Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Table Europe Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Gene Therapy Revenue Market Share by Countries in 2017
Figure Germany Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure France Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure UK Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Gene Therapy Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Gene Therapy Sales (K Units) by Type (2013-2018)
Table Middle East Gene Therapy Market Share by Type (2013-2018)
Figure Middle East Gene Therapy Market Share by Type (2013-2018)
Table Middle East Gene Therapy Sales (K Units) by Applications (2013-2018)
Table Middle East Gene Therapy Market Share by Applications (2013-2018)
Figure Middle East Gene Therapy Sales Market Share by Application in 2017
Table Middle East Gene Therapy Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Gene Therapy Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Gene Therapy Sales Volume Market Share by Countries in 2017
Table Middle East Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East Gene Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Gene Therapy Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Gene Therapy Sales (K Units) by Type (2013-2018)
Table Africa Gene Therapy Sales Market Share by Type (2013-2018)
Figure Africa Gene Therapy Sales Market Share by Type (2013-2018)
Figure Africa Gene Therapy Sales Market Share by Type in 2017
Table Africa Gene Therapy Sales (K Units) by Application (2013-2018)
Table Africa Gene Therapy Sales Market Share by Application (2013-2018)
Figure Africa Gene Therapy Sales Market Share by Application (2013-2018)
Table Africa Gene Therapy Sales Volume (K Units) by Countries (2013-2018)
Table Africa Gene Therapy Sales Market Share by Countries (2013-2018)
Figure Africa Gene Therapy Sales Market Share by Countries (2013-2018)
Figure Africa Gene Therapy Sales Market Share by Countries in 2017
Table Africa Gene Therapy Revenue (Million USD) by Countries (2013-2018)
Table Africa Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Africa Gene Therapy Revenue Market Share by Countries (2013-2018)
Figure Africa Gene Therapy Revenue Market Share by Countries in 2017
Figure South Africa Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Table Sangamo Gene Therapy Basic Information List
Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sangamo Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Sangamo Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Sangamo Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Spark Therapeutics Gene Therapy Basic Information List
Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Spark Therapeutics Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Spark Therapeutics Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Spark Therapeutics Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Dimension Therapeutics Gene Therapy Basic Information List
Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Dimension Therapeutics Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Avalanche Bio Gene Therapy Basic Information List
Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Avalanche Bio Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Avalanche Bio Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Avalanche Bio Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Celladon Gene Therapy Basic Information List
Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celladon Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Celladon Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Celladon Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Vical Gene Therapy Basic Information List
Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Vical Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Vical Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Vical Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Advantagene Gene Therapy Basic Information List
Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advantagene Gene Therapy Sales (K Units) and Growth Rate (2013-2018)
Figure Advantagene Gene Therapy Sales Market Share in EMEA (2013-2018)
Figure Advantagene Gene Therapy Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Manufacturers in 2017
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure EMEA Gene Therapy Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Gene Therapy Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Gene Therapy Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Gene Therapy Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Gene Therapy Sales Market Share Forecast by Region (2018-2025)
Table EMEA Gene Therapy Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Gene Therapy Revenue Market Share Forecast by Region (2018-2025)
Table Europe Gene Therapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Gene Therapy Sales Market Share Forecast by Countries (2018-2025)
Table Europe Gene Therapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Gene Therapy Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Gene Therapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Gene Therapy Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Gene Therapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Gene Therapy Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Gene Therapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Gene Therapy Sales Market Share Forecast by Countries (2018-2025)
Table Africa Gene Therapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Gene Therapy Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Gene Therapy Sales Market Share Forecast by Type (2018-2025)
Table EMEA Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Gene Therapy Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources